The US FDA has requested an additional clinical trial of TiGenix's cartilage re-generation product ChondroCelect before it can be approved, the company has said.
The US FDA has requested an additional clinical trial of TiGenix's cartilage re-generation product ChondroCelect before it can be approved, the company has said.
ChondroCelect is used to repair defects in the cartilage of the femoral condyle (the end of the thighbone) in the...
Psychedelics appear to be in vogue after years of being relegated to alternative medicine. But investor pushback after the highly anticipated release of Phase III trial data by Compass Pathways reveals an increasingly high bar for development.
Emerging Company Profile: Early-stage biotech Eolo will seek cash and deals for its novel obesity drug SANA after positive Phase I results for weight loss, lean muscle mass preservation and fat mass reduction.
Roctavian shows durable bleed control and safety over five years, but high costs and access hurdles limit its commercial outlook.
